Suppression of bone turnover following treatment with Zoledronic acid in patients with metastatic breast cancer: Duration of effect. The SubDuE study Grant uri icon

  •  
  • Overview
  •  
  • Affiliation
  •  
  • View All
  •  

date/time interval

  • July 1, 2008 - June 30, 2010

total award amount

  • CAD 133133